Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 36 matching records.
36 results — page 1 of 2
- Level CProspective StudyPubMed
Integrated RNA sequencing and in vivo biosensor imaging define the early pathogenic cascade of Duchenne muscular dystrophy.
Prospective Study on Chronic Inflammation, published in Transl Res (2026) — summary generated from the PubMed abstract.
- 2026
Transl Res - Level ASystematic ReviewEurope PMC
In vivo evaluation of decellularized skeletal muscle matrices for skeletal muscle repair: A systematic review
Systematic Review, published in Bioeng Transl Med (2025) — summary generated from the PubMed abstract.
- 2025
Bioeng Transl Med2 citations - Level DAnimal StudyPubMed
Continuous adipose-derived stem cell therapy from the neonatal stage effectively reduces Duchenne muscular dystrophy symptoms in rats.
Animal Study, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level DLaboratory StudyEurope PMC
Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models
Laboratory Study, published in Mol Biol Rep (2024) — summary generated from the PubMed abstract.
- 2024
Mol Biol Rep - Level CProspective StudyEurope PMC
Developing Advanced Chimeric Cell Therapy for Duchenne Muscular Dystrophy
Prospective Study, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci - Level DNarrative ReviewEurope PMC
Barriers to Treg therapy in Europe: From production to regulation
Narrative Review, published in Front Med (Lausanne) (2023) — summary generated from the PubMed abstract.
- 2023
Front Med (Lausanne)11 citations - Level DAnimal StudyPubMed
Enrichment of Nanofiber Hydrogel Composite with Fractionated Fat Promotes Regenerative Macrophage Polarization and Vascularization for Soft-Tissue Engineering.
Animal Study with a reported sample of 8 on Systemic / IV, published in Plast Reconstr Surg (2022) — summary generated from the PubMed abstract.
- 2022
- n = 8
Plast Reconstr Surg7 citations - Level DAnimal StudyPubMed
Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice.
Animal Study on Systemic / IV, published in Int J Mol Sci (2022) — summary generated from the PubMed abstract.
- 2022
Int J Mol Sci - Level DAnimal StudyPubMed
In utero transplantation of myoblasts and adipose-derived mesenchymal stem cells to murine models of Duchenne muscular dystrophy does not lead to engraftment and frequently results in fetal death.
Animal Study, published in Regen Ther (2022) — summary generated from the PubMed abstract.
- 2022
Regen Ther4 citations - Level DLaboratory StudyEurope PMC
QS8: Enrichment of Nanofiber Hydrogel Composite with Fractionated Fat Promotes Pro-regenerative Macrophage Polarization and Angiogenesis for Soft Tissue Engineering
Laboratory Study with a reported sample of 8 on Systemic / IV, published in Plast Reconstr Surg Glob Open (2021) — summary generated from the PubMed abstract.
- 2021
- n = 8
Plast Reconstr Surg Glob Open - Level DLaboratory StudyPubMed
The FibromiR miR-214-3p Is Upregulated in Duchenne Muscular Dystrophy and Promotes Differentiation of Human Fibro-Adipogenic Muscle Progenitors.
Laboratory Study, published in Cells (2021) — summary generated from the PubMed abstract.
- 2021
Cells - Level ASystematic ReviewEurope PMC
The Efficacy of Naïve versus Modified Mesenchymal Stem Cells in Improving Muscle Function in Duchenne Muscular Dystrophy: A Systematic Review
Systematic Review on Cardiovascular Disease, published in Biomedicines (2021) — summary generated from the PubMed abstract.
- 2021
Biomedicines7 citations - Level BClinical TrialPubMed
Endometrial SUSD2 + Mesenchymal Stem/Stromal Cells in Tissue Engineering: Advances in Novel Cellular Constructs for Pelvic Organ Prolapse.
Clinical Trial on Immune Modulation, published in J Pers Med (2021) — summary generated from the PubMed abstract.
- 2021
J Pers Med16 citations - Level DAnimal StudyPubMed
Partial Ablation of Non-Myogenic Progenitor Cells as a Therapeutic Approach to Duchenne Muscular Dystrophy.
Animal Study, published in Biomolecules (2021) — summary generated from the PubMed abstract.
- 2021
Biomolecules - Level CCase Report / SeriesEurope PMC
Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy
Case Report / Series on Immune Modulation, published in Cells (2020) — summary generated from the PubMed abstract.
- 2020
Cells17 citations - Level DAnimal StudyEurope PMC
Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy
Animal Study on Hip, Systemic / IV, published in Biol Res (2020) — summary generated from the PubMed abstract.
- 2020
Biol Res14 citations - Level CProspective StudyPubMed
Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect.
Prospective Study, published in Am J Stem Cells (2020) — summary generated from the PubMed abstract.
- 2020
Am J Stem Cells - Level DAnimal StudyPubMed
Beneficial role of adipose-derived mesenchymal stem cells from microfragmented fat in a murine model of duchenne muscular dystrophy.
Animal Study, published in Muscle Nerve (2019) — summary generated from the PubMed abstract.
- 2019
Muscle Nerve4 citations - Level CProspective StudyPubMed
Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy.
Prospective Study on Cardiovascular Disease, published in Biomaterials (2018) — summary generated from the PubMed abstract.
- 2018
Biomaterials - Level DAnimal StudyPubMed
Metabolomic Analyses Reveal Extensive Progenitor Cell Deficiencies in a Mouse Model of Duchenne Muscular Dystrophy.
Animal Study, published in Metabolites (2018) — summary generated from the PubMed abstract.
- 2018
Metabolites - Level CProspective StudyPubMed
Platelet-Derived Growth Factor BB Influences Muscle Regeneration in Duchenne Muscle Dystrophy.
Prospective Study, published in Am J Pathol (2017) — summary generated from the PubMed abstract.
- 2017
Am J Pathol - Level DLaboratory StudyPubMed
[Duchenne muscular dystrophy pathophysiology].
Laboratory Study, published in Arch Pediatr (2015) — summary generated from the PubMed abstract.
- 2015
Arch Pediatr - Level DNarrative ReviewPubMed
Skeletal muscle homeostasis in duchenne muscular dystrophy: modulating autophagy as a promising therapeutic strategy.
Narrative Review on Cardiovascular Disease, published in Front Aging Neurosci (2014) — summary generated from the PubMed abstract.
- 2014
Front Aging Neurosci - Level DLaboratory StudyEurope PMC
Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes
Laboratory Study on Type 2 Diabetes, published in PLoS One (2014) — summary generated from the PubMed abstract.
- 2014
PLoS One92 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406